WebBefore investing in our common stock, investors should carefully read the information set forth under the caption “Risk Factors” and elsewhere in this Annual Report which ... Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) is a global biotechnology platform company based in Jupiter, Florida ... WebDec 14, 2024 · Dyadic Reports Third Quarter 2024 Financial Results and Highlights Recent Company Developments. Nov 7, 2024. Dyadic to Present at Upcoming Industry and …
Vaxart, Inc. – Investor Overview
WebMar 27, 2024 · JUPITER, FL / ACCESSWIRE / July 29, 2024 / Dyadic International, Inc. ('Dyadic', 'we', 'us', 'our', or the 'Company') (NASDAQ:DYAI), a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production platform to accelerate development, lower production costs and improve the … WebJul 27, 2024 · Dyadic International, Inc. is a global biotechnology company committed to building disruptive microbial production platforms including the fungus … the plum catalyst
Dyadic to Report First Quarter 2024 Financial Results
WebDec 14, 2024 · Press Releases. Mar 7, 2024. Dyadic Provides Phase 1 Clinical Trial Update for its DYAI-100 COVID-19 Recombinant Protein RBD Booster Vaccine Candidate. Mar 1, 2024. Dyadic to Present at Roth Investor Conference and Upcoming Industry Events. Feb 2, … WebNov 10, 2024 · JUPITER, Fla., Nov. 10, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building... WebJul 27, 2024 · JUPITER, Fla., July 27, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company ... theplumednest com